# Anthropic IPO: The US Government Dispute

> How the Trump administration's clash with Anthropic appears in the S-1: the supply-chain risk designation, two court tracks, export controls, and the FTC demand.
- **Published**: 2026-11-10
- **Modified**: 2026-11-10
- **Category**: ipo
- **URL**: https://www.tldr.money/articles/ipo/anthropic-ipo-trump-administration-risk

---

The Anthropic IPO is not only a story about revenue growth and compute. The company's own prospectus spends several pages on a **dispute with the United States government**, involving the current administration, the defence department, export controls, and, separately, the Federal Trade Commission.

This page puts that record in one place, in plain English, and then asks what it means for a prospective Class A shareholder. It is a companion to the [S-1 breakdown](/articles/ipo/anthropic-ipo). It is **not** an endorsement of either side, and it is **not** a prediction of how the courts will end up.

**Last updated: 10 November 2026.** Unless another source is named, the account below follows [S-1/A No. 2, filed 10 November 2026](https://www.sec.gov/Archives/edgar/data/2130357/000162828026072484/anthropicpbc-sx1ax2.htm).

> **Educational content, not investment advice.** This page explains a US initial public offering using the company's SEC filings and official sources. tldr.money is not a SEBI-registered investment adviser or research analyst, and is not a US broker-dealer. Nothing here is a recommendation to apply for, buy, sell or hold any security. US-listed shares can lose money, including on the first day of trade. The registration statement had not yet become effective as of 10 November 2026, so the shares could not yet be sold. Read the [prospectus on EDGAR](https://www.sec.gov/Archives/edgar/data/2130357/000162828026072484/anthropicpbc-sx1ax2.htm) and speak to a qualified adviser if you need personal advice.

<div data-viz="timeline" data-id="anthropic-us-gov-timeline">February 2026 orders through the pending appeals, June export controls, and the October FTC demand, as described in the S-1.</div>

## A naming note, so the filing and the news match

In the S-1, Anthropic refers to the US defence department as the **Department of War** and to its head as the **Secretary of War**. That is the name used by the current US administration. Coverage from early 2026, and most readers in India, will still say the **Pentagon** or the **Department of Defense**. In this article, "defence department" means the same institution the filing is talking about.

## What the company says happened

<div data-card="risk" data-icon="store" data-title="The issuer's own warning">

In the notes to its financial statements, Anthropic says a portion of its revenue comes from contracts with US government agencies, and that on 27 February 2026 the President ordered the US government to stop using the company's models and the defence department designated it a supply-chain risk. The next sentence is: **"The Company may experience material revenue losses or business disruptions attributable to these events."**

</div>

The longer risk-factor narrative, slightly condensed, runs as follows.

Anthropic had a **publicly stated position** that its technology should not be used for **mass domestic surveillance** or **fully autonomous weapons**. In **February 2026**, in response to that position, the President of the United States stated that he had directed all federal executive agencies to **cease using** the company's technology. At the same time, the defence department designated Anthropic a **"supply-chain risk to national security"** and said that, effective immediately, no contractor, supplier or partner doing business with the United States military may conduct any commercial activity with the company.

On **4 March 2026** the department sent two letters: one under **10 U.S.C. § 3252**, and one under **Section 4713** of the **Federal Acquisition Supply Chain Security Act (FASCSA)**, both asserting that Anthropic's models, platform and applications present a supply-chain risk. The filing groups the February and March actions as the **"Challenged Actions."**

Anthropic sued, in **Anthropic PBC v. Department of War, et al.**, in the US District Court for the **Northern District of California**, and also sought review in the **US Court of Appeals for the D.C. Circuit**. The California court first issued a **preliminary injunction** against the directive and the Section 3252 designation, and preliminarily barred other defendant agencies from implementing the presidential directive until the case was resolved. On **27 August 2026** that court **largely granted summary judgment** for Anthropic. It held that the challenged actions were **retaliatory acts meant to punish the company for speech protected by the First Amendment**, and that they violated the company's rights under the **Due Process Clause of the Fifth Amendment**. It also held that the Secretary's actions, particularly under § 3252, violated the **Administrative Procedure Act** as in excess of statutory authority, contrary to law, and arbitrary and capricious. Final judgment was entered largely in Anthropic's favour. The defendants have filed notices of appeal of the preliminary injunction and of the final judgment.

The D.C. Circuit, however, **refused to stay** the **Section 4713** supply-chain risk designation pending review. On **25 September 2026**, in a **2-1** decision, it **denied** Anthropic's petition for review, holding that the Section 4713 designation was **proper** and that the company's First Amendment and Fifth Amendment rights were **not** violated. Anthropic has filed a petition for **rehearing en banc**, asking the full D.C. Circuit to review the panel decision. The company says it cannot predict the ultimate outcome, and cannot be certain that the resolution will not hurt its ability to sell to government agencies and to customers who themselves sell to the US government.

A later passage in the business section adds a detail worth keeping: the defendants appealed **both** the preliminary-injunction order **and** the California final judgment.

## Export controls on two models

In **June 2026**, the S-1 says, the US Department of Commerce imposed **worldwide export restrictions** on **Fable 5** and **Mythos 5**. To stay in compliance, Anthropic **disabled both models for all customers**. It says access to its other models was not affected. It **redeployed** Fable 5 and Mythos 5 after updating safeguards with the US government and industry partners, and after Commerce **lifted** the restrictions.

The filing's warning is forward-looking: similar controls could **recur**, could last longer, or could extend to additional models or capabilities, and future remedial updates might not win relief on the same timetable, or at all. That, it says, could limit hiring, research, and international availability, and could cause the company to lose customers and market share to rivals not under the same restrictions.

## The FTC demand, which is a different track

This is easy to flatten into "Washington versus Anthropic," but the S-1 treats it separately.

In **September 2026**, the filing says, media reports citing a senior FTC official indicated that the FTC had opened **non-public investigations** into the potential risks that increasingly autonomous AI systems may pose to consumers. In **October 2026** the FTC issued a **civil investigative demand** to Anthropic seeking information about consumer protection, data protection and privacy practices, and about the safety and security of its products. The demand **does not assert any claims**, and the company says it cannot predict whether the investigation will lead to a proceeding.

The S-1 also notes a voluntary arrangement with the US **Center for Advancing Innovation and Standards for Super Intelligence (CAISSI)** to provide models for **pre-deployment testing**, and refers more broadly to an uncertain regulatory environment.

Partnerships with Amazon, Google, Microsoft and Broadcom, the filing adds, have attracted and may again attract **antitrust or competition-law** scrutiny. That is flagged as a risk, not as a finding of a violation.

## What this means if you are considering the stock

None of the following is a recommendation.

**It is already in the price discovery, but it is not resolved.** A buyer of Class A shares is buying into a company whose largest customer of last resort, the US government, has been in open conflict with it, and whose military-contractor channel was formally restricted. Two serious courts have now disagreed. Until the appeals end, the legal status of at least the FASCSA designation can move.

**"Material" is the company's word, not a number.** The S-1 does not, in the passages we relied on, isolate a dollar figure for lost US-government revenue. Do not invent one. Do not assume the risk is zero because the California court was colourful in Anthropic's favour.

**Commercial customers may care even if they are not the Pentagon.** The risk factors say the dispute can produce reputational harm, delayed purchases, extra diligence, and reluctance to sign long-term contracts, including among commercial and international customers, regardless of how the litigation ends.

**Export controls are a second, shorter-fuse risk.** Fable 5 and Mythos 5 were turned off globally, then turned back on. The precedent is that a Commerce action can remove a product from every customer, not only from US agencies.

**Governance and this dispute interact.** Anthropic's public-benefit purpose and its safety stance are not marketing copy in the S-1; the company presents them as the reason it took the position that triggered the February orders. A public-benefit board can, by design, make a call that hurts the share price. If you want a company that will always prioritise access to a government contract, this structure is telling you it might not.

**For an Indian investor the legal venue is even further away.** You would be a Nasdaq Class A holder, with the limited voting power described in the [S-1 breakdown](/articles/ipo/anthropic-ipo), watching US constitutional and procurement litigation that you cannot influence. Currency and tax rules, covered in [how to invest from India](/articles/ipo/how-to-invest-in-anthropic-ipo-from-india), sit on top of that, they do not replace it.

## Related reading

- [Anthropic IPO: S-1 breakdown](/articles/ipo/anthropic-ipo)
- [How to invest in the Anthropic IPO from India](/articles/ipo/how-to-invest-in-anthropic-ipo-from-india)
- [Official IPO site, roadshow and Q3 highlights](/articles/ipo/anthropic-ipo-official-site-roadshow-q3-results)
- [Price range, shares and timeline](/articles/ipo/anthropic-ipo-price-band-date)
- [S-1 financials](/articles/ipo/anthropic-ipo-financials-s1)
- [The US government dispute](/articles/ipo/anthropic-ipo-trump-administration-risk)
- [Should you invest?](/articles/ipo/should-you-invest-in-anthropic-ipo)
- [IPO guides](/ipo)

## Sources

- [Anthropic S-1/A No. 2, 10 November 2026](https://www.sec.gov/Archives/edgar/data/2130357/000162828026072484/anthropicpbc-sx1ax2.htm): Risk Factors (government-contracts and export-controls subsections), Business (regulatory environment), and notes to the consolidated financial statements (other matters, including the 27 February 2026 orders and the "material revenue losses or business disruptions" language).
- Contemporary reporting, used only as background and not as a substitute for the filing, includes [CNBC's 13 October 2026 item on the en banc request](https://www.cnbc.com/2026/10/13/anthropic-wants-court-in-dc-to-rehear-appeal-of-pentagon-blacklist-.html) and earlier coverage of the June export-control talks. Where the news and the S-1 could diverge, this page follows the S-1.
---
- [More ipo articles](https://www.tldr.money/articles/category/ipo)
- [All articles](https://www.tldr.money/articles)